Covestor Ltd - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$65
+97.0%
2,350
+115.0%
0.05%
+96.0%
Q2 2023$33
+6.5%
1,093
+26.7%
0.02%
-7.4%
Q1 2023$31863
+8530.0%
0.03%
Q4 2022$0
-100.0%
10
-90.7%
0.00%
-100.0%
Q3 2022$4,000108
+1100.0%
0.00%
Q2 2022$0
-100.0%
9
-94.9%
0.00%
-100.0%
Q1 2022$6,000
+50.0%
177
+16.4%
0.00%
-33.3%
Q4 2021$4,0001520.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders